Cornerstone Pharmaceuticals, Inc. Initiates Phase I Clinical Trial Of CPI-613 For The Treatment Of Metastatic Colorectal Cancer

Press/Media: Press / Media

PeriodJan 12 2015

Media coverage

1

Media coverage

  • TitleCornerstone Pharmaceuticals, Inc. Initiates Phase I Clinical Trial Of CPI-613 For The Treatment Of Metastatic Colorectal Cancer
    Media name/outletBioSpace
    CountryUnited States
    Date1/12/15
    PersonsAngela Alistar